View More Recent Stories
-
TD Cowen Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
-
H.C. Wainwright Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
-
BTIG Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
-
Wolfe Research Downgrades Moonlake Immunotherapeutics (MLTX) to Peerperform
-
H.C. Wainwright Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
-
Oppenheimer Starts Moonlake Immunotherapeutics (MLTX) at Outperform
-
MoonLake Immunotherapeutics (MLTX) Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody sonelokimab in Psoriatic Arthritis

